1. Home
  2. FLNT vs COYA Comparison

FLNT vs COYA Comparison

Compare FLNT & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fluent Inc.

FLNT

Fluent Inc.

HOLD

Current Price

$3.73

Market Cap

121.1M

ML Signal

HOLD

Logo Coya Therapeutics Inc.

COYA

Coya Therapeutics Inc.

HOLD

Current Price

$5.29

Market Cap

124.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLNT
COYA
Founded
2010
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.1M
124.8M
IPO Year
2009
2022

Fundamental Metrics

Financial Performance
Metric
FLNT
COYA
Price
$3.73
$5.29
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$3.50
$15.80
AVG Volume (30 Days)
224.3K
224.9K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
41.67
N/A
EPS
N/A
N/A
Revenue
$208,764,000.00
$7,945,753.00
Revenue This Year
$5.89
N/A
Revenue Next Year
$12.62
$763.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
123.57
52 Week Low
$1.70
$3.71
52 Week High
$4.15
$7.75

Technical Indicators

Market Signals
Indicator
FLNT
COYA
Relative Strength Index (RSI) 61.99 51.15
Support Level $2.95 $3.98
Resistance Level $4.03 $6.30
Average True Range (ATR) 0.28 0.42
MACD 0.02 -0.04
Stochastic Oscillator 66.20 27.56

Price Performance

Historical Comparison
FLNT
COYA

About FLNT Fluent Inc.

Fluent Inc is a commerce media solutions provider that connects brands with engaged consumers by leveraging diverse advertising inventory, robust first-party data, and proprietary machine learning. The company mainly delivers customer acquisition services through scalable digital marketing campaigns, linking advertisers with targeted audiences. It reaches consumers through its Commerce Media Solutions, which integrate targeted advertising into e-commerce and digital media transaction flows on partner websites and mobile applications, as well as through its owned and operated digital media properties. The company operates in the United States, which generates the majority of its revenue, along with international markets.

About COYA Coya Therapeutics Inc.

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.

Share on Social Networks: